News
B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...
Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.
The Jonathan Jaques Children's Cancer Institute at Miller Children's & Women's Hospital was involved in a pivotal Children's Oncology Group study that has reshaped the standard of care for children ...
Despite failing to achieve MRD-negativity after induction, patients with Ph+ acute lymphoblastic leukemia treated with ...
News Medical on MSN2d
Universal CAR T cell therapy shows promise for aggressive T cell cancersA new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results ...
Huntsman Cancer Institute completed the first successful allogeneic stem cell transplant using cells from a deceased donor.
ABC4 Utah on MSN3d
Intermountain Health first in nation to expand stem cell collection for CAR-T Cell Therapy bringing innovative cancer procedure to Southern UtahIntermountain Health is now offering a national first-of-its kind expansion of CAR-T Cell Therapy, bringing cutting-edge cancer care closer to patients in ...
Researchers sought to determine whether venetoclax plus low-intensity chemotherapy would be effective in adult patients with ALL.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback